Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Transcriptome
100%
Prostate Cancer
100%
Risk Stratification
100%
Validation Cohort
100%
Copy number
100%
Clinical Outcomes
40%
Integrative Analysis
40%
Tumor Tissue
40%
Copy number Alterations
40%
Validation Set
20%
Tumor
20%
Expression Profile
20%
Molecular Alterations
20%
Expression Level
20%
Gene Expression
20%
Prostate Cancer Progression
20%
Patient Cohort
20%
Molecular Profile
20%
Overexpression
20%
Clinical Behavior
20%
Treatment Decisions
20%
Gleason Score
20%
Benign Tissue
20%
Early Detection
20%
Genome Analysis
20%
Relative Contribution
20%
Genomic Loci
20%
Gene Signature
20%
Clinical Setting
20%
MAP3K7
20%
Genetic Modification
20%
RB1 Deletion
20%
Gene Set
20%
Expression Quantitative Trait Loci (eQTL)
20%
Six Genes
20%
PTEN Deletion
20%
Primary Prostate Cancer
20%
Prostate Cancer Antigen 3 (PCA3)
20%
Biochemical Relapse
20%
ZBTB4
20%
Integrated Genomics
20%
ELAC2
20%
MYC Amplification
20%
Cancer Subgroups
20%
TPD52
20%
Molecular Changes
20%
High-risk Disease
20%
AMACR
20%
Patient Subgroups
20%
NKX3.1
20%
Gene Copy number
20%
Predictors of Poor Prognosis
20%
Clinical Predictors
20%
Heterogeneous Genotype
20%
Germline
20%
Affect Expression
20%
Genomic Expression
20%
Heterogeneous Phenotype
20%
Biochemistry, Genetics and Molecular Biology
Transcriptomics
100%
Genomics
100%
Cohort Study
100%
Gene Expression
25%
Messenger RNA
25%
Gleason Score
25%
Germline
25%
Germ Cell
25%
PCA3
25%
Expression Quantitative Trait Loci
25%
MAP3K7
25%
Gene Signature
25%
Expression Level
25%